Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington's disease mice

Journal of Neurochemistry

Volumn 74, Issue 5, 2000, Pages 2108-2119

  Jenkins, Bruce G ^a   Klivenyi, Peter ^a   Kustermann, Ekkehard ^a   Andreassen, Ole A ^a   Ferrante, Robert J ^b,c   Rosen, Bruce R ^a   Beal, M Flint ^a,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Glucose; Glutamine; Huntington's disease transgenic mice; N Acetyl aspartate; Spectroscopy

Indexed keywords

CHOLINE DERIVATIVE; GLUCOSE; GLUTAMIC ACID; GLUTAMINASE; GLUTAMINE; HUNTINGTIN; INOSITOL; N ACETYLASPARTIC ACID; SUCCINIC ACID; TAURINE;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN METABOLISM; CONTROLLED STUDY; ENZYME ACTIVITY; HUNTINGTON CHOREA; METABOLIC DISORDER; MOUSE; NERVE CELL NECROSIS; NEUROCHEMISTRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; ASPARTIC ACID; BLOOD GLUCOSE; BRAIN; GLUCOSE; GLUTAMINE; HUMANS; HUNTINGTON DISEASE; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MICE, TRANSGENIC; NEURONS; NONLINEAR DYNAMICS; TIME FACTORS;

ANIMALIA; MUS MUSCULUS;

EID: 0034006477     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.0742108.x     Document Type: Article

References (82)

1. Aoki C., Kaneko T., Starr A., and Pickel V. (1991) Identification of mitochondrial and non-mitochondrial glutaminase within select neurons and glia of rat forebrain by electron microscopic immunocytochemistry. J. Neurosci. Res. 28, 531-548.
2. Ardawi M. S. (1988) Glutamine and ketone-body metabolism in the gut of streptozotocin-diabetic rats. Biochem. J. 249, 565-572.
3. Argov Z. (1998) Functional evaluation techniques in mitochondrial disorders. Eur. Neurol. 39, 65-71.
4. Aylward E. H., Anderson N. B., Bylsma F. W., Wagster M. V., Barta P. E., Sherr M., Feeney J., Davis A., Rosenblatt A., Pearlson G. D., and Ross C. A. (1998) Frontal lobe volume in patients with Huntington's disease. Neurology 50, 252-258.
5. Backman L., Robins-Wahlin T. B., Lundin A., Ginovart N., and Farde L. (1997) Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes. Brain 120, 2207-2217.
6. Barkovich A. J., Good W. V., Koch T. K., and Berg B. O. (1993) Mitochondrial disorders: analysis of their clinical and imaging characteristics. AJNR Am. J. Neuroradiol. 14, 1119-1137.
7. Bates G. P. and Davies S. W. (1997) Transgenic mouse models of neurodegenerative disease caused by CAG/polyglutamine expansions. Mol. Med. Today 3, 508-515.
8. Bates G. P., Mangiarini L., Mahal A., and Davies S. W. (1997) Transgenic models of Huntington's disease. Hum. Mol. Genet. 6, 1633-1637.
9. 1H MRS studies in vivo. Neuroreport 7, 1397-1400.
10. 1H spectrum of rat brain by two-dimensional shift correlated and J-resolved NMR spectroscopy. Magn. Reson. Med. 17, 285-303.
11. Bottomley P. (1987) Spatial localization in NMR spectroscopy in vivo. Ann. NY Acad. Sci. 508, 333-348.
12. Brouillet E., Jenkins B. G., Hyman B. T., Ferrante R. J., Kowall N. W., Srivastava R., Roy D. S., Rosen B. R., and Beal M. F. (1993) Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid. J. Neurochem. 60, 356-359.
13. Burton R. F. (1983) The composition of animal cells: solutes contributing to osmotic pressure and charge balance. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 76, 663-671.
14. Butterworth J., Yates C. M., and Reynolds G. P. (1985) Distribution of phosphate-activated glutaminase, succinic dehydrogenase, pyruvate dehydrogenase and gamma-glutamyl transpeptidase in postmortem brain from Huntington's disease and agonal cases. J. Neurol. Sci. 67, 161-171.
15. Butterworth R. F., Hamel E., Landreville F., and Barbeau A. (1978) Effect of alloxan diabetes on cerebellar amino acids. Can. J. Neurol. Sci. 5, 135-137.
16. Cendes F., Andermann F., Dubeau F., Matthews P. M., and Arnold D. L. (1997) Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy. Evidence from proton MR spectroscopic imaging. Neurology 49, 1525-1533.
17. Cha J. H., Kosinski C. M., Kerner J. A., Alsdorf S. A., Mangiarini L., Davies S. W., Penney J. B., Bates G. P., and Young A. B. (1998) Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene. Proc. Natl. Acad. Sci. USA 95, 6480-6485.
18. Davie C. A., Barker G. J., Quinn N., Tofts P. S., and Miller D. H. (1994a) Proton MRS in Huntington's disease. Lancet 343, 1580.
19. Davie C. A., Hawkins C. P., Barker G. J., Brennan A., Tofts P. S., Miller D. H., and McDonald W. I. (1994b) Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 117, 49-58.
20. Davies S. W., Turmaine M., Cozens B. A., DiFiglia M., Sharp A. H., Ross C. A., Scherzinger E., Wanker E. E., Mangiarini L., and Bates G. P. (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90, 537-548.
21. Davies S. W., Beardsall K., Turmaine M., DiFiglia M., Aronin N., and Bates G. P. (1998) Are neuronal intranuclear inclusions the common neuropathology of triplet-repeat disorders with polyglutamine-repeat expansions? Lancet 351, 131-133.
22. De Stefano N., Matthews P. M., and Arnold D. L. (1995) Reversible decreases in N-acetylaspartate after acute brain injury. Magn. Reson. Med. 34, 721-727.
23. DiFiglia M., Sapp E., Chase K. O., Davies S. W., Bates G. P., Vonsattel J. P., and Aronin N. (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990-1993.
24. Dunlop D. S., McHale D. M., and Lajtha A. (1992) Decreased brain N-acetylaspartate in Huntington's disease. Brain Res. 580, 44-48.
25. Farrer L. A. (1985) Diabetes mellitus in Huntington disease. Clin. Genet. 27, 62-67.
26. Ferrante R. J., Shinobu L. A., Schulz J. B., Matthews R. T., Thomas C. E., Kowall N. W., Gurney M. E., and Beal M. F. (1997) Increased 3-nitrotyrosine and oxidative damage in mice with a human Cu,Zn Superoxide dismutase mutation. Ann. Neurol. 42, 326-334.
27. Flock E. V., Tyce G. M., and Owen C. A., Jr. (1969) Glucose metabolism in brains of diabetic rats. Endocrinology 85, 428-437.
28. 1H NMR spectra of the human brain at 4 Tesla. Magn. Reson. Med. 36, 1-6.
29. 1H NMR spectra with increased magnetic field strength. J. Magn. Reson. 135, 260-264.
30. 1H nuclear magnetic resonance spectroscopic imaging of neuronal loss in rat brain. Neuroscience 69, 1095-1101.
31. Gusella J. F. and MacDonald M. E. (1998) Huntingtin: a single bait hooks many species. Curr. Opin. Neurobiol. 8, 425-430.
32. Hassel B. and Sonnewald U. (1995) Selective inhibition of the tricarboxylic acid cycle of GABAergic neurons with 3-nitropropionic acid in vivo. J. Neurochem. 65, 1184-1191.
33. Hurlbert M. S., Zhou W., Wasmeier C., Kaddis F. G., Hullon J. C., and Freed C. R. (1999) Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes. Diabetes 48, 649-651.
34. Insarova N. G., Korshunova T. S., Mzhel'skaia T. I., and Borisova T. V. (1978) Metabolic disorders in Huntington's chorea [in Russian]. Zh. Nevropatot. Psikhiatr. Im S. S. Korsakova 78, 489-495.
35. 1H NMR spectroscopy. Neurology 43, 2689-2695.
36. Jenkins B. G., Brouillet E., Chen Y. C., Storey E., Schulz J. B., Kirschner P., Beal M. F., and Rosen B. R. (1996) Non-invasive neurochemical analysis of focal excitotoxic lesions in models of neurodegenerative illness using spectroscopic imaging. J. Cereb. Blood Flow Metab. 16, 450-461.
37. Jenkins B., Chen Y., and Rosen B. (1997) Investigating the neurochemistry and etiology of neurodegenerative disorders using magnetic resonance spectroscopy, in Mitochondria and Free Radicals in Neurodegenerative Diseases, (Beal M. F., Howell N., and Bodis-Wollner I., eds), pp. 423-470. Wiley-Liss, New York.
38. 1H NMR spectroscopy studies of Huntington's disease: correlations with CAG repeat numbers. Neurology 50, 1357-1365.
39. Kalra S., Cashman N. R., Genge A., and Arnold D. L. (1998) Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy. Neuroreport 9, 1757-1761.
40. Klement I. A., Skinner P. J., Kaytor M. D., Yi H., Hersch S. M., Clark H. B., Zoghbi H. Y., and Orr H. T. (1998) Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell 95, 41-53.
41. Klunk W. E., Panchalingam K., Moossy J., McClure R. J., and Pettegrew J. W. (1992) N-Acetyl-L-aspartate and other amino acid metabolites in Alzheimer's disease brain: a preliminary proton nuclear magnetic resonance study. Neurology 42, 1578-1585.
42. Kreis R. and Ross B. D. (1992) Cerebral metabolic disturbances in patients with subacute and chronic diabetes mellitus: detection with proton MR spectroscopy. Radiology 184, 123-130.
43. Kremer H. P., Roos R. A., Frolich M., Radder J. K., Nieuwenhuijzen Kruseman A. C., Van der Velde A., and Buruma O. J. (1989) Endocrine functions in Huntington's disease. A two-and-a-half years follow-up study. J. Neurol. Sci. 90, 335-344.
44. Kuwert T., Lange H. W., Langen K. J., Herzog H., Aulich A., and Feinendegen L. E. (1990) Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease. Brain 113, 1405-1423.
45. Kuwert T., Noth J., Scholz D., Schwarz M., Lange H. W., Topper R., Herzog H., Aulich A., and Feinendegen L. E. (1993) Comparison of somatosensory evoked potentials with striatal glucose consumption measured by positron emission tomography in the early diagnosis of Huntington's disease. Mov. Disord. 8, 98-106.
46. Law R. O. (1994) Regulation of mammalian brain cell volume. J. Exp. Zool. 268, 90-96.
47. Li S.-H. and Li X.-J. (1998) Aggregation of N-terminal huntingtin is dependent on the length of its glutamine repeats. Hum. Mol. Genet. 7, 777-782.
48. Magistretti P. J. and Pellerin L. (1997) Metabolic coupling during activation. A cellular view. Adv. Exp. Med. Biol. 413, 161-166.
49. Makar T. K., Hungund B. L., Cook G. A., Kashfi K., and Cooper A. J. L. (1995) Lipid metabolism and membrane composition are altered in the brains of type II diabetic mice. J. Neurochem. 64, 2159-2168.
50. Mangiarini L., Sathasivam K., Seller M., Cozens B., Harper A., Hetherington C., Lawton M., Trottier Y., Lehrach H., Davies S. W., and Bates G. P. (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493-506.
51. Mangiarini L., Sathasivam K., Mahal A., Mott R., Seller M., and Bates G. P. (1997) Instability of highly expanded CAG repeats in mice transgenic for the Huntington's disease mutation. Nat. Genet. 15, 197-200.
52. Mathews P. M., Andermann F., Silver K., Karpati G., and Arnold D. L. (1993) Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies. Neurology 43, 2484-2490.
53. Matthews R. T., Yang L., Jenkins B. G., Ferrante R. J., Rosen B. R., Kaddurah-Daouk R., and Beal M. F. (1998) Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease. J. Neurosci. 18, 156-163.
54. Nakada T., Hida K., and Kwee I. L. (1992) Brain pH and lactic acidosis: quantitative analysis of taurine effect. Neurosci. Res. 15, 115-123.
55. O'Brien C. F., Miller C., Goldblatt D., Welle S., Forbes G., Lipinski B., Panzik J., Peck R., Plumb S., Oakes D., Kurlan R., and Shoulson I. (1990) Extraneural metabolism in early Huntington's disease. Ann. Neurol. 28, 300-301.
56. Ordway J. M., Tallaksen-Greene S., Gutekunst C-A., Bernstein E. M., Cearley J. A., Wiener H. W., Dure L. S., Lindsey R., Hersch S. M., Jope R. S., Albin R. L., and Detloff P. J. (1997) Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse. Cell 91, 753-763.
57. Patel T. B. and Clark J. B. (1979) Synthesis of N-acetyl-L-aspartate by rat brain mitochondria and its involvement in mitochondrial/cytosolic carbon transport. Biochem. J. 184, 539-546.
58. Pellerin L., Pellegri G., Bittar P. G., Charnay Y., Bouras C., Martin J. L., Stella N., and Magistretti P. J. (1998) Evidence supporting the existence of an activity-dependent astrocyte-neuron lactate shuttle. Dev. Neurosci. 20, 291-299.
59. Podolsky S. and Leopold N. A. (1977) Abnormal glucose tolerance and arginine tolerance tests in Huntington's disease. Gerontology 23, 55-63.
60. Podolsky S., Leopold N. A., and Sax D. S. (1972) Increased frequency of diabetes mellitus in patients with Huntington's chorea. Lancet 1, 1356-1358.
61. Price D. L., Sisodia S. S., and Borchelt D. R. (1998) Genetic neurodegenerative diseases: the human illness and transgenic models. Science 282, 1079-1083.
62. Reynolds G. P., Dalton C. F., Tillery C. L., Mangiarini L., Davies S. W., and Bates G. P. (1999) Brain neurotransmitter deficits in mice transgenic for the Huntington's disease mutation. J. Neurochem. 72, 1773-1776.
63. Sakai Y., Okamoto K., and Kimura H. (1985) Pharmacological evidence for taurine as an inhibitory neurotransmitter in the cerebellum. Prog. Clin. Biol. Res. 179, 313-319.
64. Saudou F., Finkbeiner S., Devys D., and Greenberg M. E. (1998) Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95, 55-66.
65. Schuff N., Amend D. L., Meyerhoff D. J., Tanabe J. L., Norman D., Fein G., and Weiner M. W. (1998) Alzheimer disease: quantitative H-1 MR spectroscopic imaging of frontoparietal brain. Radiology 207, 91-102.
66. Shiino A., Matsuda M., Morikawa S., Inubushi T., Akiguchi I., and Handa J. (1993) Proton magnetic resonance spectroscopy with dementia. Surg. Neurol. 39, 143-147.
67. Shonk T. K., Moats R. A., Gifford P., Michaelis T., Mandigo J. C., Izumi J., and Ross B. D. (1995) Probable Alzheimer disease: diagnosis with proton MR spectroscopy. Radiology 195, 65-72.
68. Sibson N. R., Dhankhar A., Mason G. F., Rothman D. L., Behar K. L., and Shulman R. G. (1998) Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity. Proc. Natl. Acad. Sci. USA 95, 316-321.
69. Simmonds M. A. (1986) Classification of inhibitory amino acid receptors in the mammalian nervous system. Med. Biol. 64, 301-311.
70. Simmons M., Frandoza C., and Coyle J. (1991) Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 45, 37-45.
71. Smith S. A., Levante T. O., Meier B. H., and Ernst R. R. (1994) Computer simulations in magnetic resonance. An object oriented programming approach. J. Magn. Reson. 106, 75-105.
72. 1H magnetic resonance spectroscopic imaging analysis of quinolinic acid-induced damage to the rat striatum. Magn. Reson. Med. 37, 24-33.
73. Tabrizi S. J., Mangiarini L., Workman J., Mahal A., Bates G., Cooper J. M., and Schapira A. H. V. (1998) Mitochondrial biochemical features of the R6/2 transgenic mice model of Huntington's disease. Mov. Disord. 13, 153.
74. Truckenmiller M. E., Namboodiri M. A. A., Brownstein M. J., and Neale J. H. (1985) N-Acetylation of L-aspartate in the nervous system: differential distribution of a specific enzyme. J. Neurochem. 45, 1658-1662.
75. Urenjak J., Williams S. R., Gadian D. G., and Noble M. (1993) Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J. Neurosci. 13, 981-989.
76. Walsh N. P., Blannin A. K., Robson P. J., and Gleeson M. (1998) Glutamine, exercise and immune function. Links and possible mechanisms. Sports Med. 26, 177-191.
77. Watford M., Erbelding E. J., and Smith E. M. (1987) The regulation of glutamine and ketone-body metabolism in the small intestine of the long-term (40-day) streptozotocin-diabetic rat. Biochem. J. 242, 61-68.
78. Williamson D. H., Lopes-Vieira O., and Walker B. (1967) Concentrations of free glucogenic amino acids in livers of rats subjected to various metabolic stresses. Biochem. J. 104, 497-502.
79. Young A. B., Penney J. B., Starosta-Rubinstein S., Markel D. S., Berent S., Giordani B., Ehrenkaufer R., Jewett D., and Hichwa R. (1986) PET scan investigations of Huntington's disease: cerebral metabolic correlates of neurological features and functional decline. Ann. Neurol. 20, 296-303.
80. Yudkoff M., Nissim I., Hertz L., Pleasure D., and Erecińska M. (1992) Nitrogen metabolism: neuronal-astroglial relationships. Prog. Brain Res. 94, 213-224.
81. Yudkoff M., Nissim I., Daikhin Y., Lin Z. P., Nelson D., Pleasure D., and Erecińska M. (1993) Brain glutamate metabolism: neuronal-astroglial relationships. Dev. Neurosci. 15, 343-350.
82. Zielke H. R., Zielke C. L., and Ozand P. T. (1984) Glutamine: a major energy source for cultured mammalian cells. Fed. Proc. 43, 121-125.